Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
BBB-Therapeutics B.V.
National Cancer Institute (NCI)
Asan Medical Center
Vanderbilt-Ingram Cancer Center